IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

The study, backed by the WHO, was released to mark World Diabetes Day on Thursday. It conducts a comparison between the ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million - over four ...

Endocrinologists share uncommon symptoms of diabetes that may indicate type 1, type 2, or prediabetes. Some signs include ...